Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal oxytocin for female sexual dysfunction in peri- and postmenopausal women
2011-001310-34Phase 2Completed
- Sponsor
- Medical University of Vienna, Department of Internal Medicine III
- Start
- Jul 2011
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2 trial of oxytocin in female sexual dysfunction (FSD), hypoactive sexual desire disorder (HSDD), Sexual Arousal Disorder and 2 more, sponsored by Medical University of Vienna, Department of Internal Medicine III. Primary endpoint: Female Sexual Function Index (FSFI) total score. Started Jul 2011; status: completed.
02
Drugs
oxytocin
03
Conditions
female sexual dysfunction (FSD)hypoactive sexual desire disorder (HSDD)Sexual Arousal DisorderanorgasmiaMenopausal Disorder
Beyond the preview
Go deeper on 2011-001310-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001310-34.